Bobby's work sits at the interface of Biological Sciences, chemical biology, chemistry, biochemistry and genomics entailing the development and application of novel enabling technologies to basic science and disease characterisation.

His research focuses on the application of proteomics based mass spectrometry to the fields of Microbiology, Pathogens, Parasitology, Pharmacology, Biotechnology and human health. His current focus is on defining the molecular aetiology of host pathogen interactions within the gut.